arrow
C

Cliona Kirwan

Manchester University NHS Foundation Trust
H指数:37
被引数:6,537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anatomic versus reverse total shoulder replacement for patients with osteoarthritis and intact rotator cuff: the RAPSODI-UK randomised controlled trial protocol

解剖型与反转型全肩关节置换术治疗骨关节炎合并完整肩袖患者的随机对照试验方案(RAPSODI-UK)

2025-12-120
OA
Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials

基线特征预测5年内缺失患者报告生活质量数据较低返报率:IMPORT HIGH和IMPORT LOW乳腺癌放疗试验的证据

2025-11-270
OAAI
Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates

钼靶检查与病理学检查对筛查发现的DCIS大小评估的差异:风险因素及其对同侧复发率的影响

2025-09-030
PRE
Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial

IMPORT HIGH III期随机对照试验中接受追加剂量放疗的乳腺癌患者报告的五年不良反应趋势及基线预测因素

2025-07-230
OAAI
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study

患者和临床医生评估的五年正常组织效应:比较乳腺癌患者接受一周期与三周期腋窝放疗的结果——来自III期FAST-Forward试验随机淋巴结亚组研究

2025-06-010
OAAI
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

一周和三周大分割全乳腺放疗治疗早期乳腺癌: 快进III期RCT

2023-11-017
OA
Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study
2023-04-033
OAAI